HIF1A and laryngotracheoesophageal cleft: In the treatment of LC, CHE can reduce tumor growth in Lewis lung cancer transplanted mice by targeting the NF-κB/HIF-1α signaling pathway and down-regulating the expression levels of NF-κB and HIF-1α proteins, thereby achieving a therapeutic effect (Jin and Lu, 2024).